International Flavors & Fragrances stock took a hit, plunging on Wednesday following disappointing sales guidance and a dividend cut.
Stock Performance
Shares of International Flavors dropped to $75, a significant 8.6% decline, marking the largest percentage decrease since Aug. 8, 2023. According to Dow Jones Market Data, the stock ranked as the second-worst performer in the S&P 500 on Wednesday, with a 22% decrease over the past year.
Sales Forecast
The company revealed a bearish outlook after Tuesday's trading session, with 2024 revenue expected to range between $10.8 billion and $11.1 billion. This falls short of analysts' consensus of $11.42 billion and represents a downturn from the $11.48 billion generated in 2023.
CEO Outlook
Chief Executive Erik Fyrwald expressed cautious optimism about improving financial performance for shareholders in 2024 amidst prevailing uncertainties in the business landscape.
Dividend Cut
In a bid to enhance financial flexibility, International Flavors announced a significant reduction of its quarterly dividend by around 50% to 40 cents per share. The move aims to save approximately $410 million per year, primarily for accelerated balance sheet deleveraging, as per the company's statement.
Analyst Perspective
Commenting on the dividend cut, Stifel analyst Mark Astrachan noted that the decision could help IFF with balance sheet optimization. He slashed his price target on the stock from $87 to $80 following the news.
Q4 Performance
For the fourth quarter, International Flavors reported earnings of 72 cents per share, falling short of Wall Street's estimates of 76 cents. However, the revenue of $2.7 billion was in line with market expectations.
Trump's Potential Running Mates
Japan's Nikkei Record High
Related Articles
![Trump's Potential Running Mates](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Trump's Potential Running Mates
Trump reveals possible VP candidates, emphasizing common sense and capability for presidential role. Speculation grows as diverse lineup sparks intrigue for 202...
![Tesco Upgrades Guidance on Retail Earnings](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Tesco Upgrades Guidance on Retail Earnings
Tesco has upgraded its guidance on retail earnings, expecting £2.6-£2.7 billion profit by 2024. The company attributes this growth to cost reductions, easing in...
![Revolution Medicines to Acquire EQRx in $1 Billion Deal](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Revolution Medicines to Acquire EQRx in $1 Billion Deal
Revolution Medicines, a clinical-stage oncology company, is set to acquire EQRx in an all-stock deal worth $1 billion.